返回ChemicalBook首页>CAS数据库列表>51-40-1

51-40-1

中文名称 L-去甲肾上腺素酒石酸氢盐(酯)
英文名称 L-NORADRENALINE BITARTRATE
CAS 51-40-1
EINECS 编号 200-095-0
分子式 C12H17NO9
MDL 编号 MFCD00036384
分子量 319.26
MOL 文件 51-40-1.mol
更新日期 2024/03/15 10:26:23
51-40-1 结构式 51-40-1 结构式

基本信息

中文别名
(R)-4-(2-氨基-1-羟基乙基)-1,2-苯二酚重酒石酸盐一水合物
重酒石酸去甲肾上腺素
L-去甲肾上腺素酒石酸氢盐(酯)
L-去甲肾上腺素酒石酸氢盐
DL-NOREPINEPHRINE (2,5,6, Α-D2,Β-D1) D6旽CL
英文别名
(-)-ARTERENOL BITARTRATE SALT
l-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol bitartrate
L-4-(A-HYDROXY-B-AMINOETHYL)CATECHOL BITARTRATE
L-ARTERENOL BITARTRATE
L-NORADRENALINE BITARTRATE
L-(-)-NOREPINEPHRINE-(+)-BITARTRATE
L-NOREPINEPHRINE BITARTRATE
NORADRENALINE
NORADRENALINE BITARTRATE
NOREPINEPHRINE BITARTRATE
R(-)-4-(2-AMINO-1-HYDROXYETHYL)-1,2-BENZENEDIOL-(+)-TARTRATE
(-)-noradrenalineacidtartrate
(-)-noradrenalinebitartratemonohydrate
(-)-noradrenalinetartrate
(-)-norepinephrinetartrate
alpha-(aminomethyl)-3,4-dihydroxy-benzylalcoho(-)-benzylalcohotartrate(1:1)
Benzylalcohol,.alpha.-(aminomethyl)-3,4-dihydroxy-,(-)-,tartrate(1:1)
Levarterenolbitartrate
l-noradrenalinetartrate
noradrenaline,tartrate(1:1)
所属类别
原料药:抗休克血管活性药

物理化学性质

储存条件Store at 4°C, protect from light
溶解度31.93mg/mL in DMSO
熔点102-104 °C
酸度系数(pKa)8.64(at 25℃)
水溶解性31.93mg/mL in Water

安全数据

危险性符号(GHS)
GHS08,GHS06
警示词危险
危险性描述H360-H300-H330-H310
危险品运输编号3249
危险等级6.1(b)
包装类别III
毒性LD50 ivn-rat: 210 mg/kg YACHDS 7,627,79

知名试剂公司产品信息

常见问题列表

生物活性
Norepinephrine tartrate (Levarterenol tartrate) 是一种天然的应激激素和神经递质,是 β1 选择性的adrenergic receptor激动剂,EC50值为 5.37 μM。
靶点

EC50: 5.37 μM (β 1 -selective adrenergic receptor).

体外研究

Norepinephrine (NE) bitartrate monohydrate is generally considered to be a β 1 -subtype selective adrenergic agonist. Norepinephrine (NE) also has direct activity at the β 2 -adrenoceptor in higher concentrations. Adipocytes from the inguinal fat pad (iWA) or the interscapular fat pad (BA) are isolated from neonatal wild-type C57BL/6J mice and cultured. To examine the effect of activating AT2 upon β-adrenergic signaling, cAMP production is first assessed in response to Norepinephrine (NE, 10 µM) with or without CGP (10 nM) co-treatment. Norepinephrine (NE) increases cAMP as expected in iWA, and CGP does not alter this effectNorepinephrine (NE) is also known to induce lipolysis, and liberated fatty acids are required to functionally activate UCP1 protein and to stimulate heat production. CREB phosphorylation at Ser133 is increased after Norepinephrine (NE) treatment and significantly attenuated with CGP co-treatment in mouse iWA.

RT-PCR

Cell Line: Subcutaneous preadipocytes Adipocytes.
Concentration: 10 μM.
Incubation Time: 6 hours.
Result: AT2 activation suppressed Norepinephrine induced UCP1 in white adipocytes (iWA)
"51-40-1" 相关产品信息
13062-58-3 51-41-2 373360-12-4 3198-07-0 24159-36-2 29477-54-1 63704-55-2 35538-87-5 5090-29-9 490-89-1 408328-15-4 1528622-09-4 50988-14-2 1894611-03-0 2948-16-5 73660-93-2 5530-29-0 60912-82-5